| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...737648F |
| P356 | DOI | 10.1371/JOURNAL.PONE.0037648 |
| P932 | PMC publication ID | 3356285 |
| P698 | PubMed publication ID | 22624058 |
| P5875 | ResearchGate publication ID | 225059709 |
| P50 | author | Barton Haynes | Q4865631 |
| Guido Ferrari | Q56481169 | ||
| Garnett Kelsoe | Q60614752 | ||
| Georgia D. Tomaras | Q63663866 | ||
| M Anthony Moody | Q73297881 | ||
| Sallie R Permar | Q87955622 | ||
| Genevieve G Fouda | Q88408572 | ||
| Hua-Xin Liao | Q88608388 | ||
| Munir Alam | Q89520930 | ||
| Kara Anasti | Q89520956 | ||
| Shi-Mao Xia | Q114423501 | ||
| Justin Pollara | Q114519514 | ||
| P2093 | author name string | Guang Yang | |
| Xiaoying Shen | |||
| James Friedman | |||
| Shelley Stewart | |||
| P2860 | cites work | Nonneutralizing HIV-1 gp41 envelope cluster II human monoclonal antibodies show polyreactivity for binding to phospholipids and protein autoantigens | Q42170072 |
| Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class I alpha 1 peptide-binding domain. | Q42613908 | ||
| High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies | Q42939116 | ||
| Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry | Q43694761 | ||
| Defining human immunodeficiency virus (HIV) type 1 immunotypes with six human monoclonal antibodies | Q45670204 | ||
| Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection | Q45744790 | ||
| Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus | Q45759631 | ||
| Fc receptor but not complement binding is important in antibody protection against HIV. | Q46545827 | ||
| Human milk-derived B cells: a highly activated switched memory cell population primed to secrete antibodies | Q47765150 | ||
| The ‘immunologic advantage’ of HIV-exposed seronegative individuals | Q57997441 | ||
| HIV-1 autoreactive antibodies: are they good or bad for HIV-1 prevention? | Q64934974 | ||
| Chemotaxis as a mechanism for recruitment of mucosal plasma cell precursors | Q68833882 | ||
| The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences | Q73927391 | ||
| An inducible HIV type 1 gp41 HR-2 peptide-binding site on HIV type 1 envelope gp120 | Q80473704 | ||
| Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals | Q24635002 | ||
| Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1 | Q24645530 | ||
| Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120 | Q27643185 | ||
| High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses | Q28242631 | ||
| Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41 | Q28646771 | ||
| H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination | Q28743596 | ||
| Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies | Q29619015 | ||
| Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes | Q30706865 | ||
| qpcR: an R package for sigmoidal model selection in quantitative real-time polymerase chain reaction analysis | Q30843566 | ||
| SoDA: implementation of a 3D alignment algorithm for inference of antigen receptor recombinations | Q33229588 | ||
| Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers | Q33444658 | ||
| HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis | Q33479955 | ||
| Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides | Q33560772 | ||
| Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines | Q33794973 | ||
| Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M. | Q33809112 | ||
| Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting | Q34042758 | ||
| Limited contribution of mucosal IgA to Simian immunodeficiency virus (SIV)-specific neutralizing antibody response and virus envelope evolution in breast milk of SIV-infected, lactating rhesus monkeys | Q34046182 | ||
| Robust vaccine-elicited cellular immune responses in breast milk following systemic simian immunodeficiency virus DNA prime and live virus vector boost vaccination of lactating rhesus monkeys | Q34474475 | ||
| B cell responses to HIV-1 infection and vaccination: pathways to preventing infection | Q34645502 | ||
| Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia | Q34848486 | ||
| Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L | Q35012462 | ||
| An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum | Q35077677 | ||
| Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques | Q35101333 | ||
| Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies | Q35116581 | ||
| HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies | Q35192641 | ||
| Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors | Q35382871 | ||
| Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated | Q35441583 | ||
| A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses | Q35569049 | ||
| Origin of IgA-secreting plasma cells in the mammary gland | Q36336203 | ||
| Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding | Q36649958 | ||
| Potent simian immunodeficiency virus-specific cellular immune responses in the breast milk of simian immunodeficiency virus-infected, lactating rhesus monkeys | Q36996108 | ||
| Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection | Q37273158 | ||
| Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein | Q37742876 | ||
| Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. | Q40429324 | ||
| Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues | Q41632896 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| monoclonal antibody | Q422248 | ||
| P304 | page(s) | e37648 | |
| P577 | publication date | 2012-05-18 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum | |
| P478 | volume | 7 |
| Q54263363 | Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell-mediated cytotoxicity assay. |
| Q92177871 | Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models |
| Q40410573 | Broadly neutralizing antibodies suppress post-transcytosis HIV-1 infectivity. |
| Q33743734 | CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies |
| Q57177123 | Complete functional mapping of infection- and vaccine-elicited antibodies against the fusion peptide of HIV |
| Q37426168 | Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses |
| Q64062657 | HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells |
| Q35728947 | HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies |
| Q27022055 | HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design |
| Q39250593 | How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design |
| Q33620546 | Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection |
| Q35861276 | Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission |
| Q35872338 | Mother-to-Child HIV-1 Transmission Events Are Differentially Impacted by Breast Milk and Its Components from HIV-1-Infected Women |
| Q36588632 | Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants |
| Q35058698 | Restricted isotype, distinct variable gene usage, and high rate of gp120 specificity of HIV-1 envelope-specific B cells in colostrum compared with those in blood of HIV-1-infected, lactating African women |
| Q24598653 | Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milk |
| Q35737800 | The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cells |
| Q35914306 | Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates |
| Q33772637 | Which Antibody Functions are Important for an HIV Vaccine? |
Search more.